Please login to the form below

Not currently logged in
Email:
Password:

OncoMed Pharmaceuticals

This page shows the latest OncoMed Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

Sanofi enters vaccines partnership with Sutro

Sanofi enters vaccines partnership with Sutro

Dr Jeremy Bender joined from Allos as chief business officer, while Dr Aaron Sato joined from OncoMed Pharmaceuticals as VP, research.

Latest news

  • Diabetes favoured

    575. Orexo/Ortho-McNeil-Janssen. Small molecules for COPD and asthma. Discovery. 574. Oncomed Pharmaceuticals/Bayer Schering. ... ElexoPharm/Merck &Co. Aldosterone synthase targets for cardiovascular disease. Discovery. 42. Adeona Pharmaceuticals/Meda.

  • GSK to develop cancer drugs with OncoMed

    UK pharmaceutical company GlaxoSmithKline (GSK) and US-based biotech OncoMed Pharmaceuticals have partnered to discover, develop and market antibody therapeutics to target cancer stem cells. ... GSK also has option to license four OncoMed product

More from news
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • OncoMed’s CMO steps down OncoMed’s CMO steps down

    Dr Jakob Dupont to leave the clinical-stage company. OncoMed Pharmaceuticals' Dr Jakob Dupont has resigned as senior vice president and chief medical officer, and is due to step down from ... Paul Hastings, OncoMed's chairman and chief executive officer,

  • Astellas bolsters oncology clinical development leadership Astellas bolsters oncology clinical development leadership

    He brings senior leadership experience in clinical development, compliance and licensing fromOncoMed Pharmaceuticals and PDL BioPharma, as well as academic experience from the University of North Carolina's Chapel Hill School

  • Sutro Biopharma hires chief business officer and VP research Sutro Biopharma hires chief business officer and VP research

    He was also heavily involved in the acquisition of Allos by Spectrum Pharmaceuticals. ... Dr Sato joins Sutro from OncoMed Pharmaceuticals, where he served as senior director of antibody engineering.

More from appointments
Approximately 1 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health...

Latest intelligence

Rare diseases: not so rare after all
The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...